The expression of Absent in melanoma 2 (human AIM2 and murine Aim2) is found to be increased in TFH‐like cells (CD4+Bcl6+PD1+) in the peripheral blood and skin lesions of lupus patients, compared to healthy controls. Here, BCL6 is linked to systemic lupus erythematosus.